According to a large study of claims data, new-onset psychosis affects about one in 660 adolescents and young adults withADHDwhobegin taking stimulants, but the risk is doubled in those who start amphetamine compared with those who start methylphenidate.
In the first genome-wide association study of fracture nonunion, researchers at Massachusetts General Hospital have identified multiple loci that warrant investigation in the effort to address this costly outcome.
Researchers at Mass General were involved in the first study to provide genetic validation of the use of electronic health records in bipolar disorder phenotyping, which should prove to be a boon to genetic research in psychiatry generally.
By conducting one of the largest genome-wide association studies in psychiatry, researchers have expanded the understanding of the genetics of major depression—and suggest a new approach to studying who is genetically at high-risk for poor outcomes.
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.